Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Resuscitation|November 24, 2001
Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrestW Lederer, C Lichtenberger, C Pechlaner, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1996
Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologiesG A Pankuch, C Lichtenberger, M R Jacobs, et al.
Journal of Immunological Methods|September 15, 1999
A novel high-purity isolation method for human peripheral blood neutrophils permitting polymerase chain reaction-based mRNA studiesC Lichtenberger, S Zakeri, K Baier, et al.
Alimentary Pharmacology & Therapeutics|June 6, 2003
An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgiaW Reinisch, W Miehsler, C Dejaco, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 30, 2000
In vivo effects of recombinant human interleukin-10 on lymphocyte phenotypes and leukocyte activation markers in inflammatory bowel diseaseC Dejaco, W Reinisch, C Lichtenberger, et al.
Clinical and Experimental Immunology|August 22, 2003
Donor dependent, interferon-gamma induced HLA-DR expression on human neutrophils in vivoW Reinisch, C Lichtenberger, G Steger, et al.
The American Journal of Gastroenterology|October 15, 1998
Influence of topically and systemically active steroids on circulating leukocytes in Crohn's diseaseW Tillinger, C Gasche, W Reinisch, et al.
Gene Therapy|June 17, 2003
Tissue-dependent factors affect gene delivery to tumors in vivoB Smrekar, L Wightman, M F Wolschek, et al.
Transplantation Proceedings|December 17, 2011
Anti-Gal titers in healthy adults and inflammatory bowel disease patientsA Mangold, D Lebherz, P Papay, et al.
The American Journal of Gastroenterology|August 13, 1999
Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapseW Reinisch, C Gasché, W Tillinger, et al.
Pageof 2